The partnership between ASTCT, CIBMTR, and NMDP is a 2-day forum held October 2-3.
Today marks the start of the 2023 AcCELLerate Forum, a joint partnership event between American Society for Transplantation and Cellular Therapy ™, Center for International Blood and Marrow Transplant Research ® (CIBMTR), and National Marrow Donor Program®/Be The Match®, held October 2-3 virtually and in Arlington, Virginia. The forum aims to offer increased educational and advocacy opportunities to treating physicians, regulators, industry representatives, scientists, National Institutes of Health (NIH), Centers for Medicare & Medicaid Services, health insurance professionals, patients and other health care professionals involved in the area of cellular therapy. The 2-day workshop aims to discuss the changing therapeutic landscape and opportunities for collaboration, share a variety of perspectives to advance the field, and prioritize patient needs and access to novel therapies.
“The forum is addressing topics on cellular therapies that impact multiple stake holders in the field, from the regulatory landscape to important operational aspects of patient care to management and understanding of upcoming toxicities. It wraps up with a review of the pipeline of several new products and how they will impact patient care,” Marcelo Pasquini, MD, Senior Scientific Director, CIBMTR, and Professor of Medicine, Medical College of Wisconsin, who is also chairing the first main session, told CGTLive.
The forum’s main sessions include:
“[The regulatory landscape] session will focus on the impact of a rapidly evolving field, the excitement with new therapies and the challenges to bring them up to patients. As new therapies are being developed and need to be tested in clinical trials, but patients are receiving existing and approved cellular therapies in the clinic, how can new products be established? Are there any potential modifications in the regulatory approval process to address this challenge. There are no easy answers here and the session will open up with many questions,” Pasquini shared about the session he is chairing.
In looking forward to the AcCELLerate Forum, Pasquni highlighted Levine’s talk, the CAR T-cell logistics session, and the toxicity session on Day 2 as sessions he was looking forward to. He shared his excitement for the Forum, in which questions and discussions are the main focus to help “address these emerging issues and to optimize further development of the field.”
“The field of cellular therapy is growing rapidly with a tremendous impact in the practice of oncology. The forum attempts to align several important topics, including understanding of the wave of novel products coming to the clinic, expanding to newer indications, new and optimal ways to delivery therapy, understanding the concepts of point of care manufacturing, toxicities and their management,” Pasquini said.